Institutul Oncologic "Prof. Dr. Al. Trestioreanu"

Bucharest 022328

0 studies enrolling now · 2 studies all time

What they study most

First Line Non-Small Cell Lung Cancer, Metastatic Breast Cancer

Studies at this site

• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer — Completed